Vimarsana
Biggest News Aggregation in the World

Renchi Yang News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Renchi Yang. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Renchi Yang Today - Breaking & Trending Today

HUTCHMED Highlights Sovleplenib Phase III ESLIM-01 Study and Hematological Malignancy Programs Data to be Presented at the upcoming EHA2024 Congress - Vimarsana News

HUTCHMED Highlights Sovleplenib Phase III ESLIM-01 Study and Hematological Malignancy Programs Data to be Presented at the upcoming EHA2024 Congress

Published: May 17, 2024

HONG KONG, SHANGHAI and FLORHAM PARK, N.J., May 17, 2024 -- HUTCHMED Limited today announces that topline and subgroup results from the ESLIM-01 Phase III study of sovleplenib, as well as new...

Source: marketscreener.com
Related Topics:
Ying QianCheng MeiHong KongUnited StatesRenchi YangPau MontesinosZhou YiAtholl TweedieMingci CaiHall MalloXiaojun HuangFengkui ZhangXiaofan LiuBen Atwell Alex ShawWaleed GhanimaTongji Medical CollegeShanghai Jiao Tong University School Of MedicineEuropean Hematology AssociationChinese Academy Of Medical SciencesChina LimitedUniversity People HospitalUnion HospitalHuazhong University Of ScienceInstitute Of HematologyUniversity Of Oslo
HUTCHMED Data to be Presented at EHA2024 Congress | Company Announcement - Vimarsana News

HUTCHMED Data to be Presented at EHA2024 Congress | Company Announcement

Published: May 17, 2024

Investegate announcements from HUTCHMED Data to be Presented at EHA2024 Congress

Source: investegate.co.uk
Related Topics:
Cheng MeiHong KongUnited StatesYing QianFengkui ZhangWaleed GhanimaZhou YiSovleplenibin HeavilyprePau MontesinosTazemetostatplus AmdizalisibXiaojun HuangBen Atwell Alex ShawMingci CaiXiaofan LiuAtholl TweedieRenchi YangHall MalloUniversity Of OsloInstitute Of Hematologyandblood Diseases HospitalUniversity People HospitalHuazhong University Of ScienceChinese Academy Of Medical SciencesExchange CommissionChina LimitedInstitute Of Hematology
SYK Inhibitor Promising in Early Trial of Primary ITP - Vimarsana News

SYK Inhibitor Promising in Early Trial of Primary ITP

Published: April 11, 2023

Sovleplenib demonstrated 'consistent response' as second-line treatment

Source: medpagetoday.com
Related Topics:
United StatesRenchi YangMike BassettMaria LozanoEastern Cooperative Oncology GroupBlood Diseases HospitalUniversidad De Murcia
Investegate |Hutchmed China Ltd Announcements | Hutchmed China Ltd: HMPL-523 Clinical Data Presented at ASH - Vimarsana News

Investegate |Hutchmed China Ltd Announcements | Hutchmed China Ltd: HMPL-523 Clinical Data Presented at ASH

Published: December 14, 2021

Investegate announcements from Hutchmed China Ltd, HMPL-523 Clinical Data Presented at ASH

Source: investegate.co.uk
Related Topics:
United StatesGeorgia World Congress CenterHong KongMark LeeZhou YiAtholl Tweedie Freddy CrossleyBen Atwell Alex ShawRenchi YangAnnie ChengStock Exchange Of Hong KongUniversity Of Texas Md Anderson Cancer CenterChina LimitedExchange CommissionAmerican Society For HematologyData PresentedFlorham ParkAmerican SocietyAnnual MeetingPreliminary EfficacyAdult PatientsPrimary Immune ThrombocytopeniaHematology HospitalChinese AcademyPlatelet NumberWorld Congress Center
HUTCHMED Highlights HMPL-523 Clinical Data Presented at the 2021 ASH Annual Meeting - Vimarsana News

HUTCHMED Highlights HMPL-523 Clinical Data Presented at the 2021 ASH Annual Meeting

Published: December 14, 2021

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Source: apnews.com
Related Topics:
United StatesHong KongGeorgia World Congress CenterMark LeeZhou YiAtholl Tweedie Freddy CrossleyBen Atwell Alex ShawRenchi YangAnnie ChengStock Exchange Of Hong KongUniversity Of Texas Md Anderson Cancer CenterChina LimitedExchange CommissionAmerican Society For HematologyAmerican SocietyAnnual MeetingPreliminary EfficacyAdult PatientsPrimary Immune ThrombocytopeniaHematology HospitalChinese AcademyPlatelet NumberWorld Congress CenterPhasei StudyOral Syk Inhibitor